An Automated Navigation System for Deep Brain Electrode Implantation

May 1, 2024 updated by: Beijing Tiantan Hospital

An Automated Deep Brain Electrode Implantation System Assisted by Simultaneous Imaging and Electrophysiology Navigation

  1. Analysis of the correlation between imaging and electrophysiological signals.
  2. Real time analysis method for optimal implantation position.
  3. Simultaneous Imaging and electrophysiology navigation.
  4. Accuracy and security verification of navigation system.

Expectation(Hypothesis):

Develop an automated DBS surgical navigation system based on multimodal brain imaging data and neural electro-physiological signals, which can achieve real-time linkage navigation between imaging and electrophysiology, and automatically generate the optimal implantation position of DBS electrodes based on imaging and electrophysiological information through deep learning algorithms, thereby reducing DBS electrode implantation position errors and improving surgical efficacy.

Study Overview

Detailed Description

Firstly, we choose patients who voluntarily participate in this clinical study and sign an informed consent form, whose age range from 35 to 75 years old, regardless of gender. Their clinical diagnosis is consistent with typical Parkinson's disease or muscle tone disorders, and the medical history is within 20 years. Additionally, their MRI examination excludes obvious structural changes. Last but not least, patients should have basic normal vision and hearing, and good compliance.

Then, we collect general information of enrolled patients, input preoperative MRI images of the head and thin-layer CT scans with a head rest on the surgical day into the system for image processing. Connect this system to the electrophysiological signal acquisition system during DBS surgery and record the electrophysiological signals. The first one is to analyze the degree of matching between the position and length of nuclei displayed by electrophysiological signals and imaging information, and verify the matching of the intraoperative imaging electrophysiological linkage tool. At the same time, compare the position and length information of nuclei prompted by the tool with the judgment of the surgeon, and analyze the differences between it and the judgment of clinical doctors. The second one is to using an automatic analysis tool for electrophysiological signals, record the analysis results, compare the optimal electrode implantation position automatically calculated by the system with the final implantation position selected by the surgeon, calculate the differences between the two, and further analyze the differences with the judgment of clinical doctors.

Finally, This study will test the accuracy and usability of the two tools involved in DBS surgery, and collect the following indicators: 1) the length of nuclei and the position of nucleus boundaries on imaging data, the length of nuclei and the position of nucleus boundaries on electrophysiological data, the matching degree between imaging and electrophysiology, and the consistency of nucleus information interpreted by clinical doctors after imaging electrophysiology integration; 2) Using an automatic analysis tool for electrophysiological signals, record the analysis results, compare the optimal electrode implantation position automatically calculated by the system with the final implantation position selected by the surgeon, calculate the differences between the two, and further analyze the differences with the judgment of clinical doctors.

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100071
        • Beijing Tiantan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients undergoing subthalamic nucleus or globus pallidus deep brain stimulation surgery at Beijing Tiantan Hospital.

Description

Inclusion Criteria:

  • Clinical diagnosis is consistent with typical Parkinson's disease or dystonia, and the medical history is within 20 years;
  • MRI examination excludes obvious structural changes.

Exclusion Criteria:

  • Severe mental, cognitive, or psychological disorders ;
  • Contraindications to neurosurgery, such as hydrocephalus, brain atrophy, sequelae of cerebrovascular disease, heart disease, etc. Cardiovascular and cerebrovascular diseases;
  • The presence of tumors, severe abnormalities in liver and kidney function (indicators more than 3 times normal) and other concomitant diseases that seriously affect health;
  • The presence of intracranial mass, cerebrovascular disease, mental illness, and other neurological diseases , claustrophobia or implants in the body that affect MRI scans.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The accuracy of automatic electrode position analysis tools
Time Frame: 2025.12
The best placement of the electrode (indicated by coordinates) is compared with the final placement of the implant selected by the surgeon (indicated by coordinates), then the difference between the two is calculated in millimeters as the outcome measures.
2025.12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The matching of image-electrophysiology linkage tools
Time Frame: 2025.12
Record the boundary of the nucleus (in millimeters) on the imaging data and the boundary of the nucleus (in millimeters) on the electrophysiological data. The difference between these two nuclear information data is calculated as the outcome measures to verify the image-electrophysiological matching.
2025.12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

March 18, 2024

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

April 11, 2024

First Submitted That Met QC Criteria

May 1, 2024

First Posted (Estimated)

May 2, 2024

Study Record Updates

Last Update Posted (Estimated)

May 2, 2024

Last Update Submitted That Met QC Criteria

May 1, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractory Epilepsy

Subscribe